|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance of $1,617 and $1,265, respectively | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Non-Current Assets: | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right of use assets, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Secured revolving credit facility debt issuance costs, net | ||||||||||||||||||||
| Total Non-current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Current portion of secured term loan, net of debt issuance costs | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total current portion of secured term loan, net of debt issuance costs | ||||||||||||||||||||
| Promissory note payable, related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total promissory note payable, related party | ||||||||||||||||||||
| Senior secured debt | ||||||||||||||||||||
| Convertible promissory notes payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total convertible promissory notes payable | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accrued employee compensation | ||||||||||||||||||||
| Factoring liabilities | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Current portion of finance lease liabilities | ||||||||||||||||||||
| Current portion of contract liabilities | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accrued interest | ||||||||||||||||||||
| Accrued interest, related parties | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Non-current Liabilities: | ||||||||||||||||||||
| Lease liabilities, less current portion | ||||||||||||||||||||
| Lease liabilities, less current portion, net of incentives | ||||||||||||||||||||
| Secured term loan, net of current portion and debt issuance costs | ||||||||||||||||||||
| Secured revolving credit facility | ||||||||||||||||||||
| Operating lease liabilities, less current portion | ||||||||||||||||||||
| Finance lease liabilities, less current portion | ||||||||||||||||||||
| Contract liabilities, less current portion | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total Non-current Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Preferred Stock, par value $0.001, 5,000,000 shares authorized; 6,175 shares Series A, 293 shares Series B, 90 shares Series C and 8 shares Series D designated, respectively; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, par value $0.001, 2,500,000,000 shares authorized; 8,602,309 and 8,588,876 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||||||
Loading...